📰 March Phase News
March Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from March Phase. Real-time updates on events, politics, business and more.
March 13, 2024
By Sabela Ojea Mirum Pharmaceuticals said the Food and Drug Administration approved Livmarli to treat cholestatic pruritus, a feeling of itchness, in patients five years of age and older with...
August 11, 2023
Operator: Good afternoon, and thank you all for joining. I would like to welcome you all to the Mirum Pharmaceuticals Report Second Quarter 2023 Financial Results and Provide Business Update.
August 4, 2023
Operator: Hello. Welcome to Vir Biotechnology Second Quarter 2023 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
March 15, 2023
Kia will no longer offer diesel MT variants of the Carens, Sonet, or Seltos and these models now have been replaced with iMT models.
January 31, 2022
Since Xray and medical reports will be needed for those who have had these medicals submitted to NZ more than 36 months ago medical centres that conduct immigration medicals are already flooded with people seeking appointments to get their Immigration m
January 20, 2022
Indian Weekender spoke to Immigration NZ to find out how the processing of the Oneoff visa has gone so far and how INZ is gearing up for the March Phase where around 95000 applications are expected
February 23, 2021
Next phase of COVID-19 vaccinations in NH could begin by end of March Phase would focus on teachers, child care workers Share Updated: 7:07 PM EST Feb 22, 2021 Phase would focus on teachers, child care workers Share Updated: 7:07 PM EST Feb 22, 2021 Hide Transcript Show Transcript TONIGHT, NEW HAMPSHIRE IS PREPARING TO TAKE ITS NEXT STEPS TO VACCINATE AS MANY GRANITE STATERS AS POSSIBLE, WRAPPING-UP PHASE 1-B AND MOVING ON TO PHASE 2-A. >> WE’RE ON TRACK TO FINISH...
February 5, 2021
[uam_ad id="317182"] RIO DE JANEIRO, BRAZIL - The Albert Einstein Hospitals Instituto Israelita de Ensino e Pesquisa (Israeli Institute of Teaching and Research) is expected to begin in March Phase 3 trials of the Covaxin vaccine for a period ranging from 45 to 90 days, with results scheduled for May. Approximately 3,000 volunteers will be tested in five reference centers. The vaccine is being developed in India by the Bharat Biotech laboratory. According to Gláucia Vespa, an immunologist and...